Creation of a statistical model for prediction of Hodgkin's lymphoma in young adults

Articles

https://doi.org/10.37469/0507-3758-2016-62-2-285-289

Published 15.12.2016

⁺⁻
⁺⁻
⁺⁻
⁺⁻

N.N.Petrov Research Institute of Oncology

N.N.Petrov Research Institute of Oncology; St. Petersburg State Pediatric Medical University

N.N.Petrov Research Institute of Oncology

N.N.Petrov Research Institute of Oncology; I.I.Mechnikov North-West State Medical University

##article.numberofdownloads## 21

##article.numberofviews## 54

PDF (Русский)

Keywords

Hodgkin’s lymphoma
young adults
statistical model of prognosis

How to Cite

, , , & . (2016). Creation of a statistical model for prediction of Hodgkin’s lymphoma in young adults. Voprosy Onkologii, 62(2), 285–289. https://doi.org/10.37469/0507-3758-2016-62-2-285-289

Abstract

The aim of this study was to create a multi-dimensional correlation matrix of determinants giving information on the degree of influence on survival of young adults with Hodgkin’s lymphoma each variable as well as the effect of the interaction of these variables with each other. 87 patients with Hodgkin’s lymphoma at the age of 19 to 29 years (mean age 24 ± 4 years) were included in the study. Multiple matrix containing the coefficients of correlation of survival and correlation coefficients of 35 analyzed factors was of 5 significant determinants (volume of tumor lesion, stage IV of disease, E-damage, accelerated erythrocyte sedimentation rate, leukocytosis). Construction of the correlation matrix in order to select factors to be included in the equation, which contained the pair correlation coefficients of overall survival and each of factors, showed that only the volume of tumor lesion (correlation coefficient 0.2570, p = 0.026) influences on sign-result. Multiple regression equation is represented as follows ȳ=0,166667-0,227273x[volume]; R2=0,0643674507. This equation allows for given values of the factor «volume of tumor lesion” to have theoretical values of resultant sign (survival), substituting the actual values of the factor in it.

https://doi.org/10.37469/0507-3758-2016-62-2-285-289

##article.numberofdownloads## 21

##article.numberofviews## 54

PDF (Русский)

References

Колыгин Б.А., Кулева С.А. Диагностика и лечение лимфомы Ходжкина. СПб.: Гиппократ, 2009. - 208 с.

Кулева С.А., Карицкий А.П. Предиктивное значение объема опухолевого поражения при лимфоме Ходжкина с современных позиций // Вестник РАМН. - 2014. - № 11 -12. - С. 67-71.

Bleyer W.A., O’Leary M., Barr R., Ries L.A.G. (eds) (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival, 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD.

Gobbi P.G., Bassi E., Bergonzi E. et al. Tumor burden predicts treatment resistance in patients with early unfavorable of advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy // Hematol. Oncol. - 2012. - Vol. 30. - P. 194-199.

Gobbi P.G., Bergonzi M., Bassi E. et al. Tumor burden in Hodgkin’s lymphoma can be reliably estimated from a few staging parameters // Oncology reports. - 2012. - Vol. 28. - P 815-820.

Gobbi P.G., Broglia C., Giulio G. et al. The clinical value of tumor burden at diagnosis in Hodgkin lymphoma // Cancer. - 2000. - Vol. 101. - P. 1824-1834.

Gobbi P.G., Ghirardelli M.L., Solcia M. et al. Image-aided estimate of tumor burden in Hodgkin’s disease: evidence of its primary prognostic importance // J. Clin. Oncol. - 2001. - Vol. 19. - P. 1388-1394.

Hasenclever D., Diehl V. A prognostic score to predict tumor control in advanced Hodgkin’s disease // N. Engl. J. Med. - 1998. - Vol. 339. - P. 1506-1514.

Kppers R., Schmitz R., Distler V. et al. Pathogenesis of Hodgkin’s lymphoma // Eur. J. Haematol. - 2005. - Vol. 75 (Suppl. 66). - P. 26-33.

Specht L. Tumor burden as the main indicator of prognostic in Hodgkin’s disease // Eur. J. Cancer. - 1992. - Vol. 28. - P. 1982-1985.

Specht L., Nissen N.I. Hodgkin’s disease and stage // Eur. J. Haematol. - 1989. - Vol. 43. - P. 127-135.

Specht L., Nissen N.I. Prognostic factors in Hodgkin’s disease stage III with special reference to tumour burden // Eur. J. Haematol. - 1988. - Vol. 41. - P. 80-87.

Specht L., Nissen N.I. Prognostic factors in Hodgkin’s disease stage IV // Eur. J. Haematol. - 1988. - Vol. 41. - P. 359-367.

Specht L., Nissen N.I. Prognostic significance of tumour burden in Hodgkin’s disease PS I and II // Scand. J. Haematol. - 1986. - Vol. 36. - P. 367-375.

Specht L., Nordentoft A.M., Cold S. et al. Tumor burden as the most important prognostic factor in early stage Hodgkin’s disease. Relations to other prognostic factors and implications for choice of treatment // Cancer. 1988. - Vol. 61. - P. 1719-1727.

Specht L., Lauritzen A.F., Nordentoft A.M. et al. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin’s disease. The Danish National Hodgkin Study Group // Cancer. - 1990. - Vol. 65. - P. 2594-2601.

Steidl C., Connors J.M., Gascoyne R.D. Molecular pathogenesis of Hodgkin’s lymphoma: increasing evidence of the importance of microenvironment // J. Clin. Oncol. - 2011. - Vol. 29. - P. 1812-1821.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...